Cost effectiveness and budget impact of universal varicella vaccination in Russia

References

• Centers for Disease Control and Prevention. Varicella. in: the Pink Book: Epidemiology and prevention of vaccine-preventable diseases. Washington D.C: National Center for Immunization and Respiratory Diseases; 2020 [accessed 2021 May 2]. https://www.cdc.gov/vaccines/pubs/pinkbook/varicella.html .
   Google Scholar
• Riera-Montes M, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A, Nozad B, Mirinaviciute G, Flem E, Souverain A, et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017;17:353. doi:10.1186/s12879-017-2445-2 .
   PubMed Web of Science ®Google Scholar
• Sengupta N, Breuer J. A global perspective of the epidemiology and burden of Varicella-Zoster virus. Curr Pediatr Rev. 2009;5:207–11. doi:10.2174/157339609791317315 .
   Google Scholar
• Dbaibo G, Tatochenko V, Wutzler P. Issues in pediatric vaccine-preventable diseases in low- to middle-income countries. Hum Vaccin Immunother. 2016;12:2365–77. doi:10.1080/21645515.2016.1181243 .
   PubMed Web of Science ®Google Scholar
• World Health Organization. Varicella and herpes zoster vaccines: WHO position paper June 2014. Recommendations Vaccine. 2016;34:198–99. doi:10.1016/j.vaccine.2014.07.068 .
   PubMed Web of Science ®Google Scholar
• Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, Maupin TJ, Goldman GS, Tabony LJ, Brodovicz KG, et al. Varicella disease after introduction of varicella vaccine in the United States 1995-2000. Jama. 2002;287:606–11 .
   PubMed Web of Science ®Google Scholar
• García Cenoz M, Castilla J, Chamorro J, Martínez-Baz I, Martínez-Artola V, Irisarri F, Arriazu M, Ezpeleta C, and Barricarte A. Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain 2006 to 2012. Eurosurveillance. 2013;18:20552. doi:10.2807/1560-7917.ES2013.18.32.20552 .
   Web of Science ®Google Scholar
• Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ. 2014;92:593–604. doi:10.2471/BLT.13.132142 .
   PubMed Web of Science ®Google Scholar
• Marin M, Watson TL, Chaves SS, Civen R, Watson BM, Zhang JX, Perella D, Mascola L, Seward JF. Varicella among adults: data from an active surveillance project 1995-2005. J Infect Dis. 2008;197(Suppl 2):S94–s100. doi:10.1086/522155 .
   PubMedGoogle Scholar
• Quian J, Rüttimann R, Romero C, Dall’-Orso P, Cerisola A, Breuer T, Greenberg M, Verstraeten T. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Arch Dis Child. 2008;93:845–50. doi:10.1136/adc.2007.126243 .
   PubMed Web of Science ®Google Scholar
• Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Human Vaccine Immunotherapeutics. 2019;15:645–57. doi:10.1080/21645515.2018.1546525 .
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary. Geneva: World Health Organization; 2020 [accessed 2021 May 5]. http://apps.who.int/immunization_monitoring/globalsummary/schedules .
   Google Scholar
• Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor). On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2017. 2018 [accessed 2021 June 3]. https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=10145 .
   Google Scholar
• Baryshev MA, Chernyavskaya OP, Saltykova TS. Experience of the varicella vaccine introduction into regional vaccination schedule of the Russian Federation. Epidemiol Vaccinal Prev. 2019;18:67–74. doi:10.31631/2073-3046-2019-18-6-67-74 .
   Google Scholar
• Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor). Государственный доклад О состоянии санитарно-эпидемиологического благополучия населения в российской федерации в 2019 году; 2020 [accessed 2021 July 15]. https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933 .
   Google Scholar
• Vankova O, Ulanova T, Loparev V. P1438 seroprevalence and genotyping of varicella zoster virus strains in the Russian Federation. Int J Antimicrob Agents. 2007;29. doi:10.1016/S0924-8579(07)71277-3 .
   Web of Science ®Google Scholar
• Peredelskaya EA, Safyanova TV, Druchanov MM. Clinical and epidemiological characteristics of chickenpox in children aged 0–17 in Barnaul. J Infectol. 2021;13:66–70. doi:10.22625/2072-6732-2021-13-1-66-70.
   Google Scholar
• Druzhinina T. Chickenpox in the Yaroslavl region. Economic efficiency of varicellation of one age-group of children. Pediatr Pharmacol (New York). 2012;9:14–21. doi:10.15690/pf.v9i5.450 .
   Google Scholar
• Brisson M, Edmunds WJ. Varicella vaccination in England and Wales: cost-utility analysis. Arch Dis Child. 2003;88:862–69. doi:10.1136/adc.88.10.862 .
   PubMed Web of Science ®Google Scholar
• Government of the Russian Federation. Decree of the Government of the Russian Federation of December 8, 2017 No. 1492 “on the program of state guarantees of free provision of medical care to citizens for 2018 and for the planning period of 2019 and 2020”. Moscow: Ministry of Health of the Russian Federation; 2017 [accessed 2021 May 9]. http://www.garant.ru/products/ipo/prime/doc/71729300/ .
   Google Scholar
• State Register of Medicine. State register of maximum selling prices. Russian Federation; 2009 [accessed 2021 Apr 13]. http://grls.rosminzdrav.ru/PriceLims.aspx?Torg=%d0%92%d0%b0%d1%80%d0%b8%d0%bb%d1%80%d0%b8%d0%ba%d1%81&Mnn=&RegNum=&Mnf=&Barcode=&Order=&PageSize=8&orderby=pklimprice&orderType=desc&pagenum=1 .
   Google Scholar
• Emiss. Number of births (without stillbirths) per year. Russia: State Statistics [accessed 2021 May 6]. http://apps.who.int/immunization_monitoring/globalsummary/schedules .
   Google Scholar
• Katz AL, Webb SA. Informed consent in decision-making in pediatric practice. Pediatrics. 2016;138:e20161485. doi:10.1542/peds.2016-1485 .
   PubMed Web of Science ®Google Scholar
• RosInfoStat. Mortality statistics according to Rosstat: RosInfoStat; 2021 [accessed 2021 Augt 13]. https://rosinfostat.ru/smertnost/#i-4.
   Google Scholar
• Federal State Statistics Service (ROSSTAT). Fertility according to rosstat data: RosInfoStat; 2021 [accessed 2021 July 14]. https://rosinfostat.ru/rozhdaemost/ .
   Google Scholar
• GlaxoSmithKline Biologicals SA. Инструкция по медицинскому применению лекарственного препарата варилрикс®/varilrix®: GlaxoSmithKline Biologicals SA; 2020 [accessed 2021 July 16]. https://gskpro.com/content/dam/global/hcpportal/ru_RU/varilrix/pdf/varilrix_pil_gds_v012_2017_05_11_aw_2017_06_19.pdf .
   Google Scholar
• Povey M, Henry O, Riise Bergsaker MA, Chlibek R, Esposito S, Flodmark CE, Gothefors L, Man S, Silfverdal SA, Štefkovičová M, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet Infect Dis. 2019;19:287–97. doi:10.1016/S1473-3099(18)30716-3 .
   PubMed Web of Science ®Google Scholar
• Federal Statistics Service. Key figure- Russia. Russian Federation; 2019 [accessed 2021 Mar 6]. https://www.gks.ru/free_doc/new_site/m-sotrudn/eng_site/Key_Figures.pdf .
   Google Scholar
• Federal Tax Service of Russia. Налог на доходы физических лиц (НДФЛ); 2021 [accessed 2021 July 15]. https://www.nalog.gov.ru/rn77/taxation/taxes/ndfl/ .
   Google Scholar
• Shakhanina IL, Gorelov AV, Lytkina IN, Tolkushin AG. Economic assessment of vaccine prevention of children pox on the example of Moscow. Epidemiology Infect Dis. 2009;3:49–56 .
   Google Scholar
• Teplova TE, Teplova EG Организацияи совершенствование медицинскогообеспеченияигосударственногосанитарноэпидемиологического надзора. предупреждение и ликвидация последствий чрезвычайных ситуаций. 2012: medicine of extreme situations. [accessed 2021 July 27]. https://cyberleninka.ru/article/n/ekonomicheskaya-effektivnost-vaktsinoprofilaktiki-vetryanoy-ospy-v-usloviyah-priblizhennyh-k-obscherossiyskim/viewer .
   Google Scholar
• International Society for Pharmacoeconomics and Outcomes Research. Pharmacoeconomic guidelines around the world - Russian Federation 2018. 2018: ISPOR Russia HTA regional chapter. [accessed 2021 May 4]. https://tools.ispor.org/PEguidelines/countrydet.asp?c=18&t=4 .
   Google Scholar
• Teptsova TS, Musina NZ, Omelyanovsky VV. Evaluation of the reference value of the incremental parameter “cost-effectiveness” for Russian healthcare system (in Russ.). FARMAKOEKONOMIKA Modern Pharmacoeco Pharmacoepidemiol. 2020;13:367–76. doi:10.17749/2070-4909/farmakoekonomika.2020.071 .
   Google Scholar
• Yagudina RI, Sorokovikov IV. Methodology for conducting cost-benefit analysis in pharmacoeconomic research. 2012: Методология фармакоэкономического анализа. [accessed 2021 July 27]. https://cyberleninka.ru/article/n/metodologiya-provedeniya-analiza-zatraty-poleznost-pri-provedenii-farmakoekonomicheskih-issledovaniy .
   Google Scholar
• Ksenofontova O, Rozhkova L, Savvinova T, Kharitonov A. Experience of vaccine prevention for varicella in Yekaterinburg. Pediatr Pharmacol (New York). 2010;7:34–36 .
   Google Scholar
• Tatochenko V, Ksenofontova O, Rozhkova L, Savvinova T, Kharitonov A. Post-Exposure immunological prevention against varicella. Pediatr Pharmacol (New York). 2010;7:30–33 .
   Google Scholar
• Smirnova SS, Yuzhanina TS, Stepanova EA, Rupysheva TA. ВЕТРЯНАЯ ОСПА: РИСК-ОРИЕНТИРОВАННАЯ МОДЕЛЬ УПРАВЛЕНИЯ ЭПИДЕМИЧЕСКИМ ПРОЦЕССОМ '‘Flowpox: A risk-based epidemic control model’’. Far East J Infect Pathol. 2020;39:63–68 .
   Google Scholar
• Filippov O, Bolshakova N, Elagina T, Novikova Y, Shapovalova R, Aristova A. Regional schedule of vaccination in Moscow: history, development, prospects. Epidemiol Vaccinal Prev. 2020;19:63–75. doi:10.31631/2073-3046-2020-19-4-63-75 .
   Google Scholar
• Experts Nuo I Resolutions of the expert council on vaccine prevention. Moscow: Ministry of Health of the Russian Federation. [accessed 2021 July 24]. https://www.pediatr-russia.ru/information/vaktsinatsiya/natsionalnyy-nezavisimyy-ekspertnyy-sovet-po-immunoprofilaktike/natsionalnyy-soyuz-ekspertov-v-sfere-immunoprofilaktiki-.php .
   Google Scholar
• Vishneva EA, Kostinov MP, Mazankova LN, Malinnikova EY, Namazova-Baranova LS, Plakida AV, Privalova TE, Rtishchev AY, Tatochenko VK, Fedoseenko MV, et al. Resolution of the expert forum of Russian Federation '‘chickenpox: serious infection in Russian Federation, which can be prevented due to vaccination. Curr Pediatr. 2019;18:491–94 .
   Google Scholar
• Seward JF, Jumaan AO. VSV: persistence in the population. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007 .
   Google Scholar
• Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016. doi:10.1038/nrdp.2015.16 .
   PubMed Web of Science ®Google Scholar